)
Edge26 Jun 2026
The Universal Language: Inventing the Barcode
How lines in the sand on a Miami beach became the most scanned symbol in human history, and why it took decades for anyone to care.
Kymera Therapeutics
Kymera Therapeutics (KYMR) investor relations material
Kymera Therapeutics AGM 2026 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.AGM 2026 summary24 Jun, 2026
Opening remarks and agenda
Chairperson welcomed attendees and introduced board members and executive officers present at the meeting.
The independent registered public accounting firm, Ernst & Young, was introduced.
The meeting agenda was outlined, referencing the Notice of Annual Meeting and Proxy Statement.
Board and executive committee updates
Board members and executive officers were formally introduced, including roles such as Chief Legal Officer, Chief Medical Officer, Chief Business Officer, and Chief Financial Officer.
Shareholder proposals
Proposal 1: Election of four Class III directors to serve until the 2029 annual meeting.
Proposal 2: Non-binding advisory vote to approve named executive officer compensation.
Proposal 3: Ratification of Ernst & Young as independent registered public accounting firm for fiscal year ending December 31, 2026.
Analyze the 96.16% shareholder turnout rate
Identify the Class III directors elected until 2029
Confirm the say-on-pay advisory vote outcome
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Kymera Therapeutics
- KT-621 achieved >90% STAT6 degradation, strong Th2 biomarker reduction, and excellent safety.KYMR
Study Result30 Jun 2026 - Oral degraders show biologics-like efficacy and safety, targeting vast unmet needs in immunology.KYMRCorporate presentation10 Jun 2026
- KT-621 advances in Phase IIb trials, aiming to transform type 2 inflammation treatment.KYMRJefferies Global Healthcare Conference 20263 Jun 2026
- KT-621 and pipeline degraders advance with strong safety, robust enrollment, and strategic expansion.KYMRRBC Capital Markets Global Healthcare Conference 202619 May 2026
- KT-621 and IRF5 advance in clinical trials, targeting large unmet needs in immunology.KYMRBank of America Global Healthcare Conference 202618 May 2026
- KT-621 and KT-579 advanced in clinic; $1.55B cash runway supports late-stage trials and growth.KYMRQ1 202630 Apr 2026
- Virtual meeting to elect directors, approve pay, and ratify auditor, with strong governance focus.KYMRProxy filing29 Apr 2026
- Key votes include director elections, executive pay approval, and auditor ratification.KYMRProxy filing29 Apr 2026
- Advancing oral immunology therapies with robust pipeline and strong financial runway.KYMRBarclays 28th Annual Global Healthcare Conference12 Mar 2026
Next Kymera Therapeutics earnings date
Q2 202610 Aug, 2026
Kymera Therapeutics
Next Kymera Therapeutics earnings date
Q2 202610 Aug, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage